Buck AK - Search Results

1

Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.

Luster M, Karges W, Zeich K, Pauls S, Verburg FA, Dralle H, Glatting G, Buck AK, Solbach C, Neumaier B, Reske SN, Mottaghy FM. Luster M, et al. Among authors: buck ak. Thyroid. 2010 May;20(5):527-33. doi: 10.1089/thy.2009.0342. Thyroid. 2010. PMID: 20450432

2

[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].

Buchmann I, Guhlmann CA, Elsner K, Gfrörer W, Schirrmeister H, Kotzerke J, Buck A, Reske SN. Buchmann I, et al. Nuklearmedizin. 1999;38(8):319-22. Nuklearmedizin. 1999. PMID: 10615665 German.

3

Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells.

Shen C, Buck A, Mehrke G, Polat B, Gross H, Bachem M, Reske S. Shen C, et al. Nucleic Acids Res. 2001 Feb 1;29(3):622-8. doi: 10.1093/nar/29.3.622. Nucleic Acids Res. 2001. PMID: 11160882 Free PMC article.

4

Elevated FDG uptake in the lactating human breast.

Dankerl A, Schirrmeister H, Buck A, Reske SN. Dankerl A, et al. Clin Nucl Med. 2001 Jun;26(6):577-8. doi: 10.1097/00003072-200106000-00031. Clin Nucl Med. 2001. PMID: 11353322 No abstract available.

5

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study.

Bunjes D, Buchmann I, Duncker C, Seitz U, Kotzerke J, Wiesneth M, Dohr D, Stefanic M, Buck A, Harsdorf SV, Glatting G, Grimminger W, Karakas T, Munzert G, Döhner H, Bergmann L, Reske SN. Bunjes D, et al. Blood. 2001 Aug 1;98(3):565-72. doi: 10.1182/blood.v98.3.565. Blood. 2001. PMID: 11468151 Free article. Clinical Trial.

6

Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.

Schirrmeister H, Buck A, Guhlmann A, Reske SN. Schirrmeister H, et al. Thyroid. 2001 Jul;11(7):677-83. doi: 10.1089/105072501750362754. Thyroid. 2001. PMID: 11484897

7

Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation.

Reske SN, Bunjes D, Buchmann I, Seitz U, Glatting G, Neumaier B, Kotzerke J, Buck A, Martin H, Döhner H, Bergmann L. Reske SN, et al. Eur J Nucl Med. 2001 Jul;28(7):807-15. doi: 10.1007/s002590100544. Eur J Nucl Med. 2001. PMID: 11504076 Clinical Trial.

8

Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.

Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, Dziuk K, Gabelmann A, Reske SN, Hetzel M. Schirrmeister H, et al. Among authors: buck ak. J Nucl Med. 2001 Dec;42(12):1800-4. J Nucl Med. 2001. PMID: 11752076 Free article.

9

The bone scan in osteomyelosclerosis.

Schirrmeister H, Bommer M, Buck A, Reske SN. Schirrmeister H, et al. J Bone Miner Res. 2001 Dec;16(12):2361. doi: 10.1359/jbmr.2001.16.12.2361. J Bone Miner Res. 2001. PMID: 11760853 Free article. No abstract available.

10

Initial results in the assessment of multiple myeloma using 18F-FDG PET.

Schirrmeister H, Bommer M, Buck AK, Müller S, Messer P, Bunjes D, Döhner H, Bergmann L, Reske SN. Schirrmeister H, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):361-6. doi: 10.1007/s00259-001-0711-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002711 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters